coiaward2010

Understanding CML terminology - our new CML glossary

We have now launched the CML glossary, which explains terms that are commonly used in the context of CML, specifically in medical publications. You can access the glossary here: http://www.cmladvocates.net/glossary

All terms of the glossary are automatically being highlighted in articles all across the CML Advocates Network website, so when we publish e.g. our ASH reports, all terms contained in the glossary are explained by just moving your mouse on all terms marked with a fine dotted line.

We will be extending the glossary over the next couple of weeks, but as a community-run glossary, we appreciate your help! If you would like to suggest a glossary term that we've not covered so far, please suggest it here: http://www.cmladvocates.net/newglossaryterm. The glossary is released under Creative Commons License, so feel free to re-use.


 
   
 

EU e-Privacy Directive

Please donate!

Please donate!

LogIn

Tweet Feed

cmlnet
Check our global database run by patients for #patients with 51 current #CML #clinicaltrials which have been initia… twitter.com/i/web/status/9…

Thursday, 24 May 2018

ZPWLC
“When looking at statistics, it is important to remember that we are not talking about decimal points on a graph, b… twitter.com/i/web/status/9…

Retweeted Thursday, 24 May 2018

LMC_PACIENTES
From 26 April “Sprycel is indicated for the treatment of paediatric patients with: newly diagnosed Ph+ CML in chron… twitter.com/i/web/status/9…

Retweeted Saturday, 19 May 2018